A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma

Clinical trial NCT00352742 · TERMINATED

Trial details

NCT number: NCT00352742
Sponsor: Attenuon
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2006-06-01
Primary completion: 2008-09-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.